Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer

The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations

(2018) David W. Ollila et al.   ANNALS OF SURGICAL ONCOLOGY

Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer

(2018) Monica Morrow et al.   JAMA Oncology

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

(2018) Viviana Galimberti et al.   LANCET ONCOLOGY

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes

(2017) Deshka Foster et al.   JOURNAL OF SURGICAL ONCOLOGY

Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status

(2016) Martinus A. Beek et al.   BREAST CANCER RESEARCH AND TREATMENT

Is there a role for axillary reverse mapping in the current management of breast cancer treatment?

(2016) E.J.Th. Rutgers et al.   EJSO

Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?

(2016) Nicholas K. Ngui et al.   JOURNAL OF SURGICAL ONCOLOGY

Systematic review of axillary reverse mapping in breast cancer

(2015) M. Ahmed et al.   BRITISH JOURNAL OF SURGERY

Is axillary reverse mapping feasible in breast cancer patients?

(2015) M. Noguchi et al.   EJSO

Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-Year results of trial and out-trial patients

(2014) G. Martelli et al.   EJSO

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

(2014) Mila Donker et al.   LANCET ONCOLOGY

Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: A randomized clinical trial (INT09/98)

(2013) Roberto Agresti et al.   CANCER

Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema

(2013) M. Gennaro et al.   EJSO

Axillary Recurrence After a Tumor-Positive Sentinel Lymph Node Biopsy Without Axillary Treatment: A Review of the Literature

(2012) Claire M. T. P. Francissen et al.   ANNALS OF SURGICAL ONCOLOGY

Relationship Between the Lymphatic Drainage of the Breast and the Upper Extremity: A Postmortem Study

(2012) David Pavlista et al.   ANNALS OF SURGICAL ONCOLOGY

Analysis of direct oil contrast lymphography of upper limb lymphatics traversing the axilla – A lesson from the past – Contribution to the concept of axillary reverse mapping

(2012) D. Pavlista et al.   EJSO

New anatomical classification of the axilla with implications for sentinel node biopsy

(2010) K. B. Clough et al.   BRITISH JOURNAL OF SURGERY

Extensive Nodal Disease May Impair Axillary Reverse Mapping in Patients With Breast Cancer

(2009) Riccardo Ponzone et al.   JOURNAL OF CLINICAL ONCOLOGY